The acceptability of the AMBITION-cm treatment regimen for HIV-associated cryptococcal meningitis: Findings from a qualitative methods study of participants and researchers in Botswana and Uganda

BACKGROUND: The AMBITION-cm trial for HIV-associated cryptococcal meningitis demonstrated that a single, high-dose of liposomal amphotericin (AmBisome) plus 14-days of oral flucytosine and fluconazole was non-inferior in terms of all-cause mortality to 7-days of amphotericin B deoxycholate and flucy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawrence, David S., Ssali, Agnes, Moshashane, Neo, Nabaggala, Georgina, Maphane, Lebogang, Harrison, Thomas S., Meya, David B., Jarvis, Joseph N., Seeley, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632910/
https://www.ncbi.nlm.nih.gov/pubmed/36279300
http://dx.doi.org/10.1371/journal.pntd.0010825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632910/
https://www.ncbi.nlm.nih.gov/pubmed/36279300
http://dx.doi.org/10.1371/journal.pntd.0010825

Ejemplares similares